Physical Violence and Aggression in Parkinson's Disease: A Systematic Review

被引:0
|
作者
Jones, Melissa B. [1 ,2 ]
Gibson, Lakeshia [3 ,4 ]
Gimenez-Zapiola, Malena [1 ,2 ]
Guerra, Ana [1 ,2 ]
Bhatti, Gursimrat [1 ,2 ]
Broadway, Dakota [1 ,2 ]
Tea, Juliann [1 ,2 ]
Prasad, Aksa [1 ,2 ,5 ]
Gates, Rachel [2 ,6 ]
Hinton, Elizabeth [3 ]
Jorge, Ricardo E. [1 ,2 ]
Marsh, Laura [1 ,2 ]
机构
[1] Michael E DeBakey VA Med Ctr, Houston, TX USA
[2] Baylor Coll Med, Dept Med, Houston, TX USA
[3] Univ Mississippi, Med Ctr, Jackson, MS USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Univ Texas Rio Grande Valley, Edinburg, TX USA
[6] UCHealth Univ Colorado Hosp, Aurora, CO USA
来源
JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY | 2024年 / 65卷 / 04期
关键词
Parkinson disease; violence; aggression; deep brain stimulation; DEEP BRAIN-STIMULATION; NEUROPSYCHIATRIC INVENTORY; SYMPTOMS; BEHAVIOR; DEMENTIA; SCALE; PREVALENCE; CAREGIVERS; AGITATION; VALIDITY;
D O I
10.1016/j.jaclp.2024.01.007
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Physical violence and aggression (PVA), defined as behaviors with the potential to cause bodily injury, are unfortunate risks in the management of all- cause neurodegenerative dementias. While dementia in Parkinson's disease (PD) may not be evident for many years after clinical onset, neuropsychiatric disturbances occur at all stages of the disease. At issue is whether PVA in PD is associated with clinical factors that can be targets for prevention and management in the absence of a prevailing dementia syndrome. Objective: This systematic review examined the extent to which PVA in PD without dementia is a clinically significant concern and whether it is associated with factors that could warrant proactive management. Methods: A systematic search of 9 electronic databases used MeSH headings and equivalent terms for PD, aggression, and violence. Eligible manuscripts were original articles that were published in peer- reviewed journals and reported on adults with PD in the awake state with PVA as possible outcomes. Extracted data included study design, PD ascertainment methods and characteristics, PVA assessment methods, subject demographics, psychiatric and medical comorbidities, and pertinent results. Inciting and confounding factors were extracted from case reports. Quality assessment tools were applied in accordance with the study design (e.g., observational, qualitative, or case report). Results: The search identified 10 manuscripts: 2 observational quantitative studies (total n with PD = 545), 1 qualitative study (n with PD = 20), and 7 case reports (n = 7). The observational studies suggested that PVA is less common than other neuropsychiatric disturbances, but heterogeneous methods and quality concerns prevented further conclusions. In the case reports, all patients were male, and most were early onset. In 6 of the reports, PVA occurred in the context of bilateral sub- thalamic nucleus deep brain stimulation. Conclusions: PVA, while relatively rare in PD, can be a significant management issue that is associated with select premorbid characteristics and antiparkinsonian motor treatments. As PVA may be under-reported, further understanding of its frequency, causes, risk factors, and outcomes would benefit from its systematic assessment, ideally using self-report and informant-based questionnaires.
引用
收藏
页码:366 / 378
页数:13
相关论文
共 50 条
  • [41] Alexithymia in Parkinson's disease: A systematic review of the literature
    Assogna, Francesca
    Cravello, Luca
    Orfei, Maria Donata
    Cellupica, Nystya
    Caltagirone, Carlo
    Spalletta, Gianfranco
    PARKINSONISM & RELATED DISORDERS, 2016, 28 : 1 - 11
  • [42] Systematic review of antidepressant therapies in Parkinson's disease
    Chung, TH
    Clarke, CE
    Deane, KHO
    Ghazi-Noori, S
    Rickards, H
    MOVEMENT DISORDERS, 2002, 17 : S76 - S76
  • [43] Systematic review of therapies for depression in Parkinson's disease
    Deane, K. H.
    Chung, T. H.
    Ghazi-Noori, S.
    Rickards, H.
    Clarke, C. E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 298 - 299
  • [44] Neuroprotection Trials in Parkinson's Disease: Systematic Review
    Hart, Robert G.
    Pearce, Lesly A.
    Ravina, Bernard M.
    Yaltho, Toby C.
    Marler, John R.
    MOVEMENT DISORDERS, 2009, 24 (05) : 647 - 654
  • [45] Neuroimaging of anxiety in Parkinson's disease: a systematic review
    Carey, G.
    Gormezoglu, M.
    Dujardin, K.
    Leentjens, A.
    MOVEMENT DISORDERS, 2020, 35 : S375 - S375
  • [46] A systematic review of loss of independence in Parkinson's disease
    Macleod, Angus D.
    Grieve, J. W. Kerr
    Counsell, Carl E.
    JOURNAL OF NEUROLOGY, 2016, 263 (01) : 1 - 10
  • [47] Systematic review of paramedical therapies for Parkinson's disease
    Deane, KHO
    Ellis-Hill, C
    Jones, D
    Whurr, R
    Ben-Shlomo, Y
    Playford, ED
    Clarke, CE
    MOVEMENT DISORDERS, 2002, 17 (05) : 984 - 991
  • [48] A systematic review of loss of independence in Parkinson’s disease
    Angus D. Macleod
    J. W. Kerr Grieve
    Carl E. Counsell
    Journal of Neurology, 2016, 263 : 1 - 10
  • [49] Treatment of Dysphagia in Parkinson's Disease: A Systematic Review
    Lopez-Liria, Remedios
    Parra-Egeda, Jennifer
    Vega-Ramirez, Francisco A.
    Manuel Aguilar-Parra, Jose
    Trigueros-Ramos, Ruben
    Jose Morales-Gazquez, Maria
    Rocamora-Perez, Patricia
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (11) : 1 - 13
  • [50] A systematic review of salivary biomarkers in Parkinson's disease
    De Bartolo, Maria
    Belvisi, Daniele
    Mancinelli, Romina
    Costanzo, Matteo
    Caturano, Claudia
    Leodori, Giorgio
    Berardelli, Alfredo
    Fabbrini, Giovanni
    Vivacqua, Giorgio
    NEURAL REGENERATION RESEARCH, 2024, 19 (12) : 2613 - 2625